116 related articles for article (PubMed ID: 30994011)
1. Stability studies of rifampicin in plasma and urine of tuberculosis patients according to the European Medicines Agency Guidelines.
Mishra P; Pawar RP; Bose D; Durgbanshi A; Albiol-Chiva J; Peris-Vicente J; Esteve-Romero J; Jain A
Bioanalysis; 2019 Apr; 11(8):713-726. PubMed ID: 30994011
[No Abstract] [Full Text] [Related]
2. A method to quantify several tyrosine kinase inhibitors in plasma by micellar liquid chromatography and validation according to the European Medicines Agency guidelines.
Garrido-Cano I; García-García A; Peris-Vicente J; Ochoa-Aranda E; Esteve-Romero J
Talanta; 2015 Nov; 144():1287-95. PubMed ID: 26452960
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of FASTPlaqueTB-RIF for determination of rifampicin resistance in Mycobacterium tuberculosis complex isolates.
Kisa O; Albay A; Bedir O; Baylan O; Doganci L
Int J Tuberc Lung Dis; 2003 Mar; 7(3):284-8. PubMed ID: 12661845
[TBL] [Abstract][Full Text] [Related]
4. Development of a method to determine axitinib, lapatinib and afatinib in plasma by micellar liquid chromatography and validation by the European Medicines Agency guidelines.
Albiol-Chiva J; Esteve-Romero J; Peris-Vicente J
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Feb; 1074-1075():61-69. PubMed ID: 29331859
[TBL] [Abstract][Full Text] [Related]
5. Can diabetes mellitus modify the plasma concentrations of rifampicin in patients under treatment for tuberculosis?
Fonseca AAD; Pinto ACG; Paixão TPD; Albério CAA; Vieira JLF
Braz J Infect Dis; 2020; 24(4):352-355. PubMed ID: 32535111
[TBL] [Abstract][Full Text] [Related]
6. Use of Micellar Liquid Chromatography to Determine Mebendazole in Dairy Products and Breeding Waste from Bovine Animals.
Prasad Pawar R; Mishra P; Durgbanshi A; Bose D; Albiol-Chiva J; Peris-Vicente J; García-Ferrer D; Esteve-Romero J
Antibiotics (Basel); 2020 Feb; 9(2):. PubMed ID: 32075155
[TBL] [Abstract][Full Text] [Related]
7. A method to determine two antibiotics prescribed to treat nosocomial infections in plasma and urine by micellar liquid chromatography.
Peris-Vicente J; Albiol-Chiva J; Bose D; Durgbanshi A; Carda-Broch S
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jun; 1225():123777. PubMed ID: 37290211
[TBL] [Abstract][Full Text] [Related]
8. Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis.
Srivastava K; Das R; Jakhmola P; Gupta P; Chauhan DS; Sharma VD; Singh HB; Sachan AS; Katoch VM
Indian J Med Res; 2004 Aug; 120(2):100-5. PubMed ID: 15347859
[TBL] [Abstract][Full Text] [Related]
9. Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin.
Mariana N; Purwantyastuti ; Instiaty ; Rusli A
Acta Med Indones; 2016 Jan; 48(1):10-6. PubMed ID: 27241539
[TBL] [Abstract][Full Text] [Related]
10. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of efavirenz, rifampicin and its metabolite desacetyl rifampicin levels in human plasma.
Fox D; O'Connor R; Mallon P; McMahon G
J Pharm Biomed Anal; 2011 Dec; 56(4):785-91. PubMed ID: 21840662
[TBL] [Abstract][Full Text] [Related]
12. Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method.
Panchagnula R; Sood A; Sharda N; Kaur K; Kaul CL
J Pharm Biomed Anal; 1999 Jan; 18(6):1013-20. PubMed ID: 9925337
[TBL] [Abstract][Full Text] [Related]
13. CYP2B6 genotype, but not rifampicin-based anti-TB cotreatments, explains variability in long-term efavirenz plasma exposure.
Mukonzo JK; Nanzigu S; Waako P; Ogwal-Okeng J; Gustafson LL; Aklillu E
Pharmacogenomics; 2014 Aug; 15(11):1423-35. PubMed ID: 25303294
[TBL] [Abstract][Full Text] [Related]
14. Influence of rifampicin on nevirapine plasma concentration in HIV-TB coinfected patients.
Nafrialdi ; Nugroho AW; Yunihastuti E; Wiria MS
Acta Med Indones; 2012 Apr; 44(2):135-9. PubMed ID: 22745144
[TBL] [Abstract][Full Text] [Related]
15. Role of individual drugs in the chemotherapy of tuberculosis.
Mitchison DA
Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648
[TBL] [Abstract][Full Text] [Related]
16. Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin.
Manosuthi W; Sungkanuparph S; Thakkinstian A; Vibhagool A; Kiertiburanakul S; Rattanasiri S; Prasithsirikul W; Sankote J; Mahanontharit A; Ruxrungtham K
AIDS; 2005 Sep; 19(14):1481-6. PubMed ID: 16135901
[TBL] [Abstract][Full Text] [Related]
17. From the Centers for Disease Control and Prevention. Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin.
JAMA; 1996 Nov; 276(19):1546. PubMed ID: 8918842
[No Abstract] [Full Text] [Related]
18. Rifampicin bioavailability: a review of its pharmacology and the chemotherapeutic necessity for ensuring optimal absorption.
Ellard GA; Fourie PB
Int J Tuberc Lung Dis; 1999 Nov; 3(11 Suppl 3):S301-8; discussion S317-21. PubMed ID: 10593709
[TBL] [Abstract][Full Text] [Related]
19. Rapid detection of mutations in rpoB gene of rifampicin resistant Mycobacterium tuberculosis strains by line probe assay.
Sharma M; Sethi S; Mishra B; Sengupta C; Sharma SK
Indian J Med Res; 2003 Feb; 117():76-80. PubMed ID: 12931842
[TBL] [Abstract][Full Text] [Related]
20. A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis.
Morcillo N; Zumarraga M; Alito A; Dolmann A; Schouls L; Cataldi A; Kremer K; van Soolingen D
Int J Tuberc Lung Dis; 2002 Nov; 6(11):959-65. PubMed ID: 12475141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
